Nxera Pharma Dirección
Dirección controles de criterios 2/4
El CEO de Nxera Pharma es Chris Cargill, nombrado en Mar 2022, tiene una permanencia de 2.67 años. posee directamente un 0.046% de las acciones de la empresa, con un valor de ¥47.36M. La antigüedad media del equipo directivo y de la junta directiva es de 2.7 años y 5.7 años, respectivamente.
Información clave
Chris Cargill
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 2.7yrs |
| Participación del CEO | 0.05% |
| Permanencia media de la dirección | 2.7yrs |
| Promedio de permanencia en la Junta Directiva | 5.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Nxera Pharma Co., Ltd. (TSE:4565) Stocks Pounded By 25% But Not Lagging Industry On Growth Or Pricing
Sep 25
Nxera Pharma Co., Ltd.'s (TSE:4565) P/S Still Appears To Be Reasonable
Jun 26Is Nxera Pharma (TSE:4565) A Risky Investment?
Apr 06Sosei Group Corporation (TSE:4565) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Mar 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -JP¥4b |
| Jun 30 2024 | n/a | n/a | -JP¥10b |
| Mar 31 2024 | n/a | n/a | -JP¥9b |
| Dec 31 2023 | n/a | n/a | -JP¥7b |
| Sep 30 2023 | n/a | n/a | -JP¥3b |
| Jun 30 2023 | n/a | n/a | JP¥2b |
| Mar 31 2023 | n/a | n/a | JP¥1b |
| Dec 31 2022 | JP¥292m | JP¥88m | JP¥382m |
| Sep 30 2022 | n/a | n/a | -JP¥383m |
| Jun 30 2022 | n/a | n/a | -JP¥224m |
| Mar 31 2022 | n/a | n/a | JP¥100m |
| Dec 31 2021 | JP¥231m | JP¥65m | JP¥1b |
| Sep 30 2021 | n/a | n/a | JP¥1b |
| Jun 30 2021 | n/a | n/a | JP¥1b |
| Mar 31 2021 | n/a | n/a | JP¥1b |
| Dec 31 2020 | JP¥157m | JP¥53m | JP¥1b |
| Sep 30 2020 | n/a | n/a | -JP¥2b |
| Jun 30 2020 | n/a | n/a | -JP¥1b |
| Mar 31 2020 | n/a | n/a | -JP¥332m |
| Dec 31 2019 | JP¥101m | JP¥40m | JP¥1b |
Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Chris es razonable en comparación con empresas de tamaño similar en el mercado JP.
Compensación vs. Ingresos: La compensación de Chris ha aumentado mientras la empresa no es rentable.
CEO
Chris Cargill (40 yo)
2.7yrs
Permanencia
JP¥292,000,000
Compensación
Mr. Christopher Cargill, also known as Chris, serves as Representative Executive Officer, President, Chief Executive Officer and Director at Nxera Pharma Co., Ltd. (formerly known as Sosei Group Corporatio...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Chairman of the Board | 19.4yrs | JP¥332.00m | 0.66% ¥ 675.1m | |
| Representative Executive Officer | 2.7yrs | JP¥292.00m | 0.046% ¥ 47.4m | |
| Executive Officer | 2.7yrs | sin datos | 0.0016% ¥ 1.6m | |
| Executive VP & COO | less than a year | sin datos | sin datos | |
| Executive Officer | 2.7yrs | sin datos | 0.0077% ¥ 7.8m | |
| Executive Officer | 6.8yrs | sin datos | 0.0093% ¥ 9.5m | |
| VP of Investor Relations & Head of Regulatory Disclosures | no data | sin datos | sin datos | |
| Associate Director & Head of Biophysics | no data | sin datos | sin datos | |
| Executive Officer | 1.7yrs | sin datos | 0.0063% ¥ 6.5m | |
| Head of Business Development for Japan and the APAC region | less than a year | sin datos | sin datos | |
| President of Nxera Pharma Japan & Exe Officer | less than a year | sin datos | sin datos | |
| Hd. of Drug Disc. & UK R&D | 2.7yrs | sin datos | 0.0031% ¥ 3.2m |
2.7yrs
Permanencia media
48yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 4565 se considera experimentado (2.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Chairman of the Board | 19.4yrs | JP¥332.00m | 0.66% ¥ 675.1m | |
| Representative Executive Officer | 2.7yrs | JP¥292.00m | 0.046% ¥ 47.4m | |
| Member of Scientific Advisory Board | 1.2yrs | JP¥134.00m | sin datos | |
| Independent External Director | 4.7yrs | sin datos | 0.016% ¥ 16.3m | |
| Independent External Director | 13.4yrs | sin datos | 0.057% ¥ 58.2m | |
| External Independent Director | 5.7yrs | sin datos | 0.038% ¥ 38.8m | |
| Independent External Director | 6.4yrs | sin datos | 0.040% ¥ 40.4m | |
| Independent External Director | 6.4yrs | sin datos | 0.0073% ¥ 7.4m | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| External Independent Director | 2.7yrs | sin datos | 0.013% ¥ 12.8m |
5.7yrs
Permanencia media
66yo
Promedio de edad
Junta con experiencia: La junta directiva de 4565 se considera experimentada (5.7 años de antigüedad promedio).